Print Page | Contact Us | Report Abuse | Sign In | Join
Online CME
Share |

Welcome to the CME online e-learning page! Below you will find interactive, multimedia enriched educational activities. Please click on a category below to learn more.

NMA 2015 Psychiatry Composite from NSCI Group on Vimeo.
New Guidelines: Diagnosis, Treatment and Medications Across Mental and Medical Therapeutic Areas
From the Psychiatry and Behavioral Health Section held August 5, 2016 at the 113th NMA Annual Convention and Scientific Assembly in Detroit, MI
William D. Richie, M.D - Moderator

 
Faculty:
William B. Lawson, M.D., Ph.D.
Schizophrenia New Paradigms: “First Episode” and “Community Treatment:” Using Long-Acting Injectable Antipsychotic Medications to Reduce Relapse and Hospitalizations 
Rahn Kennedy Bailey, M.D.
Assessing Schizophrenia Medications: Review of Benefits and Risks for Managing Long-Acting Injectable Antipsychotics in Community Practices
Annelle B. Primm, M.D., M.P.H.
Managing Common Medical Comorbidities in People with Schizophrenia
 
Please click here to download a PDF copy of the course book.

 

 

NMA 2015 Family Medicine:Psychiatry from NSCI Group on Vimeo.
Expanded Uses of Long-Acting Injectables Antipsychotic Medications for Community-Level Schizophrenia Management
From the Psychiatry and Behavioral Health Section held August 4, 2016 at the 113th NMA Annual Convention and Scientific Assembly in Detroit, MI
Annelle B. Primm, M.D., M.P.H. - Moderator



Faculty:
Rahn Kennedy Bailey, M.D.
Examining Barriers of Managing the Diagnosis and Treatment of Schizophrenia
William B. Lawson, M.D., Ph.D. Pharmacological Management: Interface of Diagnosis and Treatment to Reduce the Relapse Rates in Depression and Bipolar 
William D. Richie, M.D.
Differentiating the Clinical Implications of Bipolar Disorders, Attention Deficit Disorders and Autism Spectrum Illness 
Please click here to download a PDF copy of the course book.


Current Online CME Activities

Integrating GLP-1 Inhibitors into a Comprehensive Diabetes Care Management Regimen – The Incretin Experience

This enduring activity features video and audio recording from the 2015 National Medical Association Scientific Assembly, Family Medicine Section held August 3rd in Detroit, Michigan. This activity is intended for primary care and family medicine physicians, endocrinologists, internists, nurse practitioners, and other healthcare professionals interested in diabetes.

Gap/Needs Assessment:

African American patients are more likely than white patients to have diabetes.  The risk of diabetes is 77% higher among African Americans than among non-Hispanic white Americans.  The rates of diagnosis of diabetes in non-Hispanic African Americans is 18.7% compared to 7.1% of non-Hispanic white Americans. That is 4.9 million African American adults with diagnosed or undiagnosed diabetes.  In 2006, African American men were 2.2 times more likely to start treatment for ESRD related to diabetes than non-Hispanic white men.  In the same year, African Americans with diabetes were 1.5 times more likely to be hospitalized and 2.3 times more likely to die from diabetes than non-Hispanic whites.  African Americans are almost 50% more likely to develop diabetic retinopathy than non-Hispanic whites.

Learning Objectives:

Upon completion of this activity, participants should be able to:

  1. Summarize the efficacy, safety, and tolerability of GLP-1 agonists.
  2. Identify patients who would benefit from GLP-1 agonist therapy and those for whom it may not be appropriate.
  3. Describe in patient-appropriate terms how GLP-1 agonists can improve glycemic control.
  4. Compare and contrast GLP-1 agonists, other incretin-based therapies, and traditional oral agents.
  5. Develop evidence-based treatment plans to incorporate incretin therapies in combination with oral agents and insulin for optimal glycemic control.

Faculty Disclosures:

The following speakers/planners have indicated relationships with commercial interests:

Morris L. Brown, M.D.
Consulting/Speakers’ Bureau
Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Novo Nordisk

James R. Gavin III, M.D., Ph.D.
Speakers Bureau
Astra Zeneca, Boehringer Ingelheim, Eli Lilly
Consultant/Speaker
Janssen

The following speakers/planners have indicated no relevant relationships with commercial interests:
Warren A. Jones, M.D.
Kwabena Adubofour, M.D.

Acknowledgement of Commercial Support:
This activity was supported in part by educational grants from Janssen, Merck Sharp & Dohme Corp, and Novo Nordisk.

Click here to download a PDF copy of the syllabus.

Expires November 1, 2016


Ebola Facts: Informational PowerPoint and FAQ Safe Management of Patients with Ebola Virus Disease (EVD) in U.S. Hospitals Updated 10/21/2014
In response to the Ebola public health emergency, the American Hospital Association (AHA) in conjunction with the Accreditation Council for Continuing Medical Education (ACCME) and the Centers for Disease Control and Prevention (CDC), have provided an ebola education package (click the links below). This package contains information that the AHA believes would be useful to healthcare providers and institutions right now.Informational PowerPoint: Ebola Facts (October 14, 2014)FAQ: Safe Management of Patients with Ebola Virus Disease (EVD) in U.S. Hospitals (October 14, 2014)Ebola Hospital Preparedness Checklist (October 15, 2014)Surgical Protocol for Possible or Confirmed Cases of Ebola (October 16, 2014)Please note: These materials are current as of the date indicated. Users should consult the Centers for Disease Control (CDC ) or other cited sources on the day they access this information to get the most current information or version that may now be available. If you have specific questions about the information and recommendations contained in the attached material, we ask that you immediately contact the CDC or your local public health authority or infection control officer for the information you seek.


Novel Approaches to the Management of Type 2 Diabetes
From the William E. Matory, Sr and Jr. M.D. Memorial Luncheon Symposium – Family Medicine Section held at the National Medical Association’s 2013 Scientific Assembly in Toronto, Ontario, Canada.
This activity was supported in part by an educational grant from Novo Nordisk Pharmaceuticals.Objectives: Upon completion of this online activity participants should be able to:Apply a patient-centered approach to incorporate guideline recommendations for intensifying therapy to achieve glycemic controlCompare the safety and efficacy of diabetes therapies in patients with Type 2 Diabetes Identify the mechanism of action of incretin-mimetic agents and their potential for lowering fasting plasma glucose and postprandial glucose. Discuss evidence-based combination pharmacotherapy in Type 2 diabetes.


Navigating the Complex World of Cancer Diagnosis and Care: How Can We Minimize Disparities?
This CME-certified Webcast contains video and downloadable slides from 8th Annual W. Montague Cobb/NMA Scientific Symposium and Lectureship - Navigating the Complex World of Cancer Diagnosis and Care: How Can We Minimize Disparities?, a prIME Oncology educational activity that was held on July 28, 2013 during the NMA Annual Convention and Scientific Assembly in Toronto, Ontario, Canada.Objectives: After successful completion of this educational activity, participants should be able to better:Identify the implications of disparities on the diagnosis and treatment of patients with cancer and employ available resources that can overcome these disparities when appropriate. Employ current evidence-based best practices when treating patients with non-small cell lung cancer and integrate recent data regarding the potential influence of disparities on clinical outcomes. Integrate recent data from trials investigating novel therapeutic approaches for gastric cancer and use effective patient navigation practices to enhance patient outcomes. Incorporate novel therapies and approaches to castration-resistant prostate cancer and consider the potential impact of disparities on patient management and outcomes.


 

Recent Advances and Challenges in HIV Clinical Care and Prevention
From the Recent Advances and Challenges in HIV Clinical Care and Prevention Luncheon Symposium - Family Medicine Section held at the National Medical Association’s 2012 Scientific Assembly in New Orleans, Louisiana.

This activity was supported by educational grants from Abbott Laboratories, Inc. Objectives:     Upon completion of this online activity participants should be able to:Discuss current approaches in management of HIV infection.Utilize new antiretroviral agents and strategies for effective use.Identify most effective culturally appropriate approaches to screen and treat patients with HIV.Describe treatment regimen for co-morbid conditions.


 

Strategies to Optimize the Management of High Risk African Americans with Diabetes, Renal Disease, and Cardiovascular Risk Factors
From the William E. Matory, Sr and Jr. M.D. Memorial Luncheon Symposium – Family Medicine Section held at the National Medical Association’s 2012 Scientific Assembly in New Orleans, Louisiana.

This activity was supported in part by an educational grant from Novo Nordisk Pharmaceuticals.

Format: 
Video modules utilizing pre and post assessment.

Objectives:
Upon completion of this online activity participants should be able to:

  1. Describe the clinical data to support the increased incidence of diabetes and renal disease in African Americans with type 2 diabetes.
  2. Describe the risk factors that contribute to worsening renal function in patients with type 2 diabetes: with a focus on the benefits of early detection and prevention.
  3. List the pros and cons of incretin based therapies in the management of high risk type 2 diabetes patients with renal impairment and cardiovascular disease.

Alpha-One-Antitrypsin Deficiency and Pulmonary Hypertension

From the 2012 Pulmonology Symposium held at the National Medical Association’s Convention & Scientific Assembly in New Orleans, Louisiana. This educational activity was made possible in part by educational grants from Baxter Healthcare Corporation, CSL Behring LLC, and Grifols.Format:             Video modules utilizing pre and post assessment.Objectives:      Upon completion of this online activity participants should be able to:Describe the association of alpha-one-antitrypsin and early onset emphysema.Recognize signs and symptoms that are suggestive of alpha-one-antitrypsin deficiency.Select appropriate tests to screen individuals for possible alpha-one-antitrypsin deficiency.Define pulmonary arterial hypertension.List the signs and symptoms associated with pulmonary hypertension.Develop a diagnostic strategy for patients with suspected pulmonary hypertension.List the treatment options available.

Facing the Challenges of Acute Management of Asthma and COPD in the Emergency DepartmentFrom the 2012 Asthma and COPD Symposium held at the National Medical Association’s Convention & Scientific Assembly in New Orleans, Louisiana. This activity was supported in part by an educational grant from Boehringer Ingelhiem Pharmaceuticals, Inc.Format:     Video modules utilizing pre and post assessment.

The Role of HPV Vaccine in Genital & Non-Genital Cancers From the 2011 Savage Boyce Walton OB – GYN Section Lecture held at the National Medical Association’s Convention and Scientific Assembly in Washington, DC. This activity was supported by an educational grant from Merck, Inc.Format: Video module utilizing lecture and post assessment.Objectives: Upon completion of this online activity participants should be able to:Describe the development of the HPV vaccine.Discuss HPV vaccines safety and efficacy.Recognize that the HPV vaccine may be effective against non-genital cancer.List the indications for use of HPV vaccine.

Colon and Rectal Cancer: A Racial DividePresented by the W. Montague Cobb NMA Health Institute in partnership with the National Medical Association, Jefferson University, and the Eastern Cooperative Oncology Group. Hosted by OncUViewTV.Format: Five video modules utilizing lectures and panel discussion with post assessments.Objectives: Upon completion of this online activity participants should be able to:Discuss the role of the President’s Cancer Panel and the advances in improving cancer treatment.Identify the cause and effect factors associated with the development of colorectal cancer.Discuss the benefits of adjuvant therapy in patients with colorectal cancer.Identify key components of and the value in personalized cancer care.

HIV and Routine Healthcare Provider Sexual History Taking Among Physicians This activity was supported by and developed in partnership with the Centers for Disease Control and Prevention; Division of HIV/AIDS Prevention (DHAP) and Division of Sexually Transmitted Diseases Prevention (DSTDP).Format: Three video modules utilizing lecture, case study vignette, and panel discussion with post assessments.Objectives: Upon completion of this online activity participants should be able to:Take appropriate sexual histories of male patients.Utilize a sexual history tool in the clinical setting screening male patients for HIV and STD risk.

CME for Licensure

Diabetes Management From the July 31, 2010 Diabetes Management and Certification Sympososium held at the National Medical Association’s Convention and Scientific Assembly in Orlando, Florida. Supported in part by an educational grant from Lifescan a Johnson & Johnson Company.Format: Five video modules utilizing lectures and post assessment.Objectives: Upon completion of this online activity participants should be able to:Explain the latest guidelines as described in the ADA Standards of Diabetes Care.Translate the latest A1C research and recommendations to better management type 2 diabetes patients.Apply latest guidelines to manage type 2 diabetes with oral medications.Know the latest diabetes research and advances in diabetes management, including the appropriate use of insulin therapy.Initiate the appropriate diabetes prevention and control measures for patients at risk for and with type 2 diabetes.

Archived Activities (credit expired – for reference use only): Global Cardiovascular Risk Reduction Human Genome Variation and Racial Disparities in Medicines Racial and Ethnic Differences in Response to Medicines: Towards Individualized Pharmaceutical Treatment Shifting Paradigms on Race and Medicine

National Medical Association | 8403 Colesville Road, Suite 820, Silver Spring, MD 20910 | 202-347-1895